SIC
ADCT icon

Salem Investment Counselors’s ADC Therapeutics ADCT Stock Holding History

Salem Investment Counselors’s Portfolio ADCT Stock Details ADCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-35
Closed -$76 – 1103
2023
Q2 		$76 Hold
35
– – ﹤0.01% 1129
2023
Q1 		$69 Hold
35
– – ﹤0.01% 1098
2022
Q4 		$134 Hold
35
– – ﹤0.01% 1059
2022
Q3 		$0 Hold
35
– – ﹤0.01% 1028
2022
Q2 		$0 Hold
35
– – ﹤0.01% 1059
2022
Q1 		$1K Hold
35
– – ﹤0.01% 952
2021
Q4 		$1K Hold
35
– – ﹤0.01% 1026
2021
Q3 		$1K Hold
35
– – ﹤0.01% 926
2021
Q2 		$1K Buy
+35
New +$812 ﹤0.01% 853

Other funds holding ADCT

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Salem Investment Counselors's ADCT Position: Q3 2023 in Review

Salem Investment Counselors sold out of ADC Therapeutics (ADCT) in Q3 2023, closing a stake of 35 shares — an estimated $76 sold.

Salem Investment Counselors first reported a position in ADCT in Q2 2021 and held it in 9 quarters. The position peaked at $1K in Q1 2022. 41 funds tracked by Wall St. Rank hold ADCT as of Q3 2023.

  • Salem Investment Counselors reported no remaining ADC Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Salem Investment Counselors sold 35 ADC Therapeutics shares in Q3 2023, an estimated $76.
  • Salem Investment Counselors first reported a position in ADC Therapeutics in Q2 2021 and held it in 9 quarters.
  • Salem Investment Counselors's ADC Therapeutics position peaked at $1K in Q1 2022.
  • 41 funds tracked by Wall St. Rank held ADC Therapeutics as of Q3 2023.

Based on Salem Investment Counselors's 13F filing for Q3 2023, filed 4 Oct 2023.